Auxilium Pharmaceuticals Inc (AUXL)

AUXL (NASDAQ:Drugs)
$31.22
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | AUXL Avg Daily Volume: 2,162,800
Last Update: 10/23/14 - 3:59 PM EDT
Volume: 0
YTD Performance: 50.60%
Open: $0.00
Previous Close: $31.22
52 Week Range: $16.71 - $33.00
Oustanding Shares: 50,354,788
Market Cap: 1,548,409,731
6-Month Chart
TheStreet Ratings Grade for AUXL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 0 3 6 6
Moderate Buy 0 1 1 1
Hold 8 4 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 2
Mean Rec. 3.00 2.13 1.78 2.03
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -10.53
Price Earnings Comparisons:
AUXL Sector Avg. S&P 500
-10.53 0.00 27.71
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
59.29% 81.72% 91.18%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.40 0.90 0.23
Net Income -100.00 -0.65 0.00
EPS -100.00 -0.66 0.00
Earnings for AUXL:
EBITDA 0.01B
Revenue 0.40B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $-0.03 $0.23 $-0.79 $0.62
Number of Analysts 2 2 2 2
High Estimate $-0.02 $0.30 $-0.70 $0.63
Low Estimate $-0.04 $0.15 $-0.88 $0.60
Prior Year $0.10 $0.19 $0.31 $-0.79
Growth Rate (Year over Year) -130.00% 18.42% -354.84% 177.85%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
May 28, 2014 | 7:37 AM EDT
AUXL was upgraded to Buy, MKM Partners said. $26 price target. Stock is down 30% since March, but Testim appears to have stabilized and...
Bearish
Apr 30, 2014 | 7:35 AM EDT
AUXL lowered its number, UBS said. Full year guidance lowered  with shrinking T-gel shrinking and downward pressure on Rx in T-gel...
Bearish
Mar 06, 2014 | 7:51 AM EST
AUXL was downgraded to Underweight, Morgan Stanley said. Valuation call, based on a $15 price target. 
Bearish
Jan 23, 2014 | 7:53 AM EST
AUXL was downgraded to Neutral, MKM Partners said. $23 price target. Valuation call, as the stock is up 25% over the past two weeks.
Bullish
May 03, 2013 | 8:26 AM EDT
AUXL was upgraded from Underweight to Equal-weight, Morgan Stanley said. Risk/reward is more attractive, following a 50% decline since ...

Portfolio Mgr. David Peltier analyzes a volatile, low-dollar drug stock.

Bearish
Nov 08, 2012 | 8:22 AM EST
Shares of AUXL now seen reaching $29, Jefferies said. Estimates also lowered on Testim miss. Buy rating.

Portfolio David Peltier finds a pharma name that's quietly growing faster than its peers.

Bullish
Aug 01, 2012 | 8:43 AM EDT
Shares of AUXL now seen reaching $32, Jefferies said. Estimates also raised on first quarter results. Buy rating.
Bullish
Aug 01, 2012 | 8:38 AM EDT
Shares of AUXL now seen reaching $32, UBS said. Estimates also increased as Testim sales ramp should drive upside. Buy rating.

Columnist Conversations

I've read recently quite a few comments about how Chinese stocks are cheap and investors should jump in. ...
Just some resistance to be aware of. Not saying it will cap the market, just that it is there for a decision....
Shares of Amazon (AMZN) are trading down below the 50% retracement level of their 2014 range in the after-hour...
Conclusion LNKD has a strong upward trend in revenue, has maintained very high gross margin % even as revenues...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.